Nia Therapeutics develops a precision neurostimulation therapy for the treatment of memory loss.
Nia Therapeutics has raised $10.4M in total funding. The most recent round was Undisclosed. The last funding was announced in February 2024.
Nia Therapeutics's investors include Creative Destruction Lab, Ben Franklin Technology Partners of Southeastern Pennsylvania.
Nia Therapeutics is headquartered in Radnor, United States.
Nia Therapeutics develops a precision neurostimulation therapy for the treatment of memory loss.
Nia Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nia Therapeutics — Funding & Investors." VCBacked, February 14, 2024, https://www.vcbacked.co/company/nia-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Nia Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nia-therapeutics
{{cite web |title=Nia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nia-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated